Publications by authors named "K Mlisana"

Background: Under South Africa's Universal Test and Treat (UTT) policy, CD4 counts are no longer required to determine HIV treatment eligibility. However, CD4 count at presentation remains an important marker of disease progression. We assessed whether CD4 testing declined in the UTT era and, if so, by how much.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) has emerged as a substantial global health challenge, with a marked rise in associated mortality. However, it often goes undetected until advanced stages, particularly in low-income and middle-income countries such as South Africa. We investigated the prevalence and progression of CKD in South Africa, utilising a subset of data from the National Health Laboratory Services Multi-morbidity Cohort.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on understanding the risk factors and timing of tuberculosis (TB) recurrence to help reduce its prevalence.
  • Data was analyzed from a large national health database in South Africa, tracking TB episodes from 2013 to 2017, including criteria for defining the beginning and end of TB episodes.
  • Results revealed that 4.7% of individuals with rifampicin-susceptible TB experienced recurrence, particularly among males and people with HIV, with most recurrences happening within the first year after treatment.
View Article and Find Full Text PDF

ART scale-up has reduced HIV mortality in South Africa. However, less is known about trends in hospital-based HIV care, which is costly and may indicate HIV-related morbidity. We assessed trends in hospital-based HIV care using the National Health Laboratory Service (NHLS) National HIV Cohort.

View Article and Find Full Text PDF

Diabetes is a major global health issue. We evaluated compliance to laboratory-based management guidelines for diabetes (type 1 and 2), essential for effective treatment and reducing diabetes-related morbidity and mortality. Our study utilized South Africa's National Health Laboratory Services (NHLS) data, focusing on patients from birth to age 80 years who underwent initial diabetes laboratory testing between January 1, 2012-January 1, 2016.

View Article and Find Full Text PDF